Trial record 1 of 221246 for:    ALL
Previous Study | Return to List | Next Study

Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified July 2016 by The First People's Hospital of Lianyungang
Sponsor:
Collaborators:
Shandong Cancer Hospital and Institute
The Affiliated Hospital of Medical College of Qingdao University
Yankuang Group General Hospital
Lianyungang Hospital Affiliated Bengbu Medical College
Suzhou Kowloon Hospital
Information provided by (Responsible Party):
The First People's Hospital of Lianyungang
ClinicalTrials.gov Identifier:
NCT02848794
First received: July 22, 2016
Last updated: July 27, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)